Fig. 5From: Discovery of a novel antibacterial protein CB6-C to target methicillin-resistant Staphylococcus aureusCB6-C was efficient in preventing infections. A Survival rates of the mice treated with CB6-C infected by MRSA (n = 10 per group). B Effect of CB6-C on bacterial survival in organs of mice. "−" represents the infection group, " + " represents CB6-C treatment group. Data are represented as mean ± SD. *p < 0.05, **p < 0.01, determined by non-parametric one-way ANOVABack to article page